Sanofi

Lemtrada Treatment Effects in MS Patients Maintained Over Seven Years
Lemtrada
Sanofi
Relapsing Remitting Multiple Sclerosis
multiple sclerosis
Flag link:
WHO says Sanofi's Dengvaxia should be used only after a dengue test—but a test doesn't yet exist
WHO says Sanofi's Dengvaxia should be used only after a dengue test—but a test doesn't yet exist
Fierce Pharma
Sanofi
Dengvaxia
dengue
vaccines
WHO
Flag link:
Advent Is Said to Near Deal to Acquire Sanofi Generics Unit
Advent Is Said to Near Deal to Acquire Sanofi Generics Unit
Bloomberg
Advent International
Sanofi
generics
M&A
Flag link:
Sanofi ups the ante in vaccines—big-time—with new €350M plant
Sanofi ups the ante in vaccines—big-time—with new €350M plant
Fierce Pharma
Sanofi
drug manufacturing
vaccines
Canada
Flag link:
Sanofi executives face more requests for charges in Dengvaxia mess as suspicious deaths mount
Sanofi executives face more requests for charges in Dengvaxia mess as suspicious deaths mount
Fierce Pharma
Sanofi
Dengvaxia
Philipines
dengue
vacciens
Flag link:
Sanofi blockbuster-to-be skin drug Dupixent fails to win gatekeeper's backing
Sanofi blockbuster-to-be skin drug Dupixent fails to win gatekeeper's backing
Fierce Pharma
Sanofi
Dupixent
NICE
Flag link:
Sanofi seeks to restore leadership in diabetes treatments
Sanofi seeks to restore leadership in diabetes treatments
GoinPharma
Sanofi
diabetes
sotagliflozin
Flag link:
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Pharmaforum
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
sotagliflozin
Flag link:
Sanofi’s high-capacity insulin pen wins FDA nod
Sanofi’s high-capacity insulin pen wins FDA nod
Drug Delivery Business News
Sanofi
insulin
insulin pen
FDA
devices
Toujeo
diabetes
Flag link:
3 Blockbuster Drug Launches to Watch In 2018
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
Flag link:
Sanofi's for-sale generics unit is too pricey, or so says dropout bidder
Sanofi's for-sale generics unit is too pricey, or so says dropout bidder
Fierce Pharma
Sanofi
M&A
generics
Nordic Capital
Flag link:
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Flag link:
Sanofi and NIH Start Trials for H7N9 Flu Vaccine
Sanofi and NIH Start Trials for H7N9 Flu Vaccine
Xtalks
Sanofi
NIH
H7N9
flu vaccines
vaccines
clinical trials
Flag link:
Drug companies are beginning to wake up to this new risk factor
Drug companies are beginning to wake up to this new risk factor
Marketwatch
pharma industry
co-pay coupons
Pfizer
Sanofi
Amgen
Novartis
Flag link:
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Fierce Pharma
AbbVie
AstraZeneca
GSK
Sanofi
Merck
Big Pharma
Flag link:
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Fierce Pharma
Amgen
Repatha
Sensipar
generics
Sanofi
Regeneron
Praluent
Flag link:
Top 5 boards for week ending March 10, 2018
Top 5 boards for week ending March 10, 2018
CP Wire
Daiichi Sankyo
Shire
Amgen
Sanofi
AstraZeneca
Flag link:
Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
Yahoo/Reuters
Regeneron
Sanofi
Praluent
insurers
clinical trials
Flag link:
Sanofi about to sell know-how and R&D center to Evotec for €60m
Sanofi about to sell know-how and R&D center to Evotec for €60m
GoinPharma
Sanofi
R&D
Evotec
Flag link:
Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives
Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives
Xconomy
Regeneron
cholesterol
drug pricing
Sanofi
Praluent
Flag link:

Pages